Pharmanutra SpA

About

Company description

Founded and guided by Chairman Andrea Lacorte and Managing Director Roberto Lacorte, PharmaNutra was established in 2003. The company develops unique nutraceutical supplements and innovative nutritional devices, taking care of the entire production process, from the proprietary raw materials to the finished product. The efficacy of the products has been demonstrated by numerous clinical studies, 79 of them published with more than 5.000 patients treated. The Group distributes and sells itsproducts in Italy and abroad. In Italy, products are sold through a network of 180 Pharmaceutical Representatives, serving doctors and also exclusively selling PharmaNutra's products to pharmacies throughout Italy. Products are sold in over 70 countries abroad, through 35 partners selected from among the finest pharmaceutical companies. PharmaNutra leads the market in the production of iron-based nutritional supplements under the SiderAL brand, where it boasts a number of important patents on sucrosomial technology. Over the years, the Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence.

Quick facts

Sales markets	Western Europe; Eastern Europe; Middle East; Asia; North America; Africa; Central/South America
Affiliated categories:	Capsules/Encapsulation \|Dietary Supplement Ingredients \|Finished Dosage Forms More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 92F50 Book a meeting See our Exhibitor Profile See full Exhibitor List

Recently at

18 mar 2019

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan We were at stand IP-6 See our Exhibitor Profile See full Exhibitor List

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 14.1J71 See our Exhibitor Profile See full Exhibitor List

19 apr 2017

CPhI Japan 2017

19 - 21 April 2017 Tokyo, Japan We were at stand IP-6 See our Exhibitor Profile See full Exhibitor List

Our Top products

Cetilar

Cetilar®, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis. Massages help ease joint and musculoskeletal pain, which can also be beneficial to sport related injuries.

More info

SiderAL Forte

Sideral is a nutritional supplement that contains Sucrosomial® Iron (Sideral® r.m) and vitamin C, aimed at treating alimentary deficiency or as a complement when higher organic levels of these nutrients are required.

More info

SiderAL Gocce Int.

The first Sucrosomial® Iron specially formulated for newborns. The iron in SiderAL® Gocce is contained within a phospholipidic sucrosomial® membrane, meaning that it is highly bioavailable. The sucrosomial® technology employed in the production of SiderAL® Gocce fully prevents the side effects ...

More info

News about Pharmanutra SpA

19 Jul 2018

Sucrosomial ® Iron award-winning product of the year by Israeli consumers

The Sucrosomial ® technology, patent of the PharmaNutra Group at the base of the SiderAL® products, continues to gain important consents from the international markets. In fact Comfort Iron, a product launched at the beginning of 2017 exclusively for the Israeli market with a formula composed of Sucrosomial® Iron and Vitamin C, was elected by Israeli consumers “Product of the Year 2018”.

19 Jul 2018

New great success for Cetilar®: PharmaNutra obtains the patent grant

A new, fundamental strategic business asset has been added to those already owned by PharmaNutra SPA. On 5 February 2018 the company received from the Italian Patent Office the patent grant for Cetilar ® RM (number 102015000044822).

19 Jul 2018

International Multidisciplinary Course on Iron Deficiency 2018: the results of the 6th edition

On April 13th and 14th Lisbon was the scene of the sixth edition of the International Multidisciplinary Course on Iron Deficiency (IMCID), organized as every year by PharmaNutra SPA in collaboration with Zambon, the company’s trading partner in the Iberian Peninsula markets. Among its participants, the Congress saw experts doctors and researchers from more than 20 different countries, confirming the real in...

19 Jul 2018

PharmaNutra’s growth one year from listing on the Stock Exchange

Double-digit growth, appreciation in the share value and a significant market cap increase: just 12 months since its listing, the Pharmanutra Group records a marked upswing on the market and prepares for new challenges